Patent · US Active

Hepatitis b core protein modulators

US11814376B2 · kind B2 · utility

0Cited by

6References

6Claims

0Family size

Assignees

ASSEMBLY BIOSCIENCES, INC. · US
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION · US

Inventors

William W. Turner, Jr. · Bloomington, US
Lee D. Arnold · Rancho Santa Fe, US
Hans Maag · Menlo Park, US
Leping Li · San Francisco, US
Mark G. Bures · Carmel, US
Simon Nicolas Haydar · South San Francisco, US
Samson Francis · Bloomington, US

Key dates

Filing date	Jan 4, 2021
Grant date	Nov 14, 2023
Priority date	—
Expiry date	Jan 4, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.